188 related articles for article (PubMed ID: 32003417)
1. Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.
Yang AN; Wang XL; Rui HR; Luo H; Pang M; Dou XM
J Nutr Health Aging; 2020; 24(2):237-241. PubMed ID: 32003417
[TBL] [Abstract][Full Text] [Related]
2. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
M FM; Molano A; Castro J; Zarranz JJ
Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
[TBL] [Abstract][Full Text] [Related]
7. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
Burhanullah MH; Tschanz JT; Peters ME; Leoutsakos JM; Matyi J; Lyketsos CG; Nowrangi MA; Rosenberg PB
Am J Geriatr Psychiatry; 2020 Jan; 28(1):64-71. PubMed ID: 31186157
[TBL] [Abstract][Full Text] [Related]
9. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.
Rosenberg PB; Mielke MM; Appleby BS; Oh ES; Geda YE; Lyketsos CG
Am J Geriatr Psychiatry; 2013 Jul; 21(7):685-95. PubMed ID: 23567400
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric Inventory in Community-Dwelling Older Adults with Mild Cognitive Impairment and Dementia.
Nunes PV; Schwarzer MC; Leite REP; Ferretti-Rebustini REL; Pasqualucci CA; Nitrini R; Rodriguez RD; Nascimento CF; Oliveira KC; Grinberg LT; Jacob-Filho W; Lafer B; Suemoto CK
J Alzheimers Dis; 2019; 68(2):669-678. PubMed ID: 30856109
[TBL] [Abstract][Full Text] [Related]
11. Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers.
Steenland K; Karnes C; Seals R; Carnevale C; Hermida A; Levey A
J Alzheimers Dis; 2012; 31(2):265-75. PubMed ID: 22543846
[TBL] [Abstract][Full Text] [Related]
12. Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.
De Vito AN; Calamia M; Weitzner DS; Bernstein JPK;
Int J Geriatr Psychiatry; 2018 Dec; 33(12):1627-1634. PubMed ID: 30276884
[TBL] [Abstract][Full Text] [Related]
13. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
14. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
[TBL] [Abstract][Full Text] [Related]
15. Relations of neuropsychiatric symptoms with disease stage, sex, and daily function in mild cognitive impairment and dementia due to Alzheimer's disease: A cross-sectional study.
Zhang W; Wang X; Lü Y; Yu W
J Psychosom Res; 2022 Oct; 161():110994. PubMed ID: 35939891
[TBL] [Abstract][Full Text] [Related]
16. Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease.
Xu L; Li T; Xiong L; Wang X; Ismail Z; Fukuda M; Sun Z; Wang J; Gauthier S; Yu X; Wang H
J Alzheimers Dis; 2021; 81(3):1141-1149. PubMed ID: 33935092
[TBL] [Abstract][Full Text] [Related]
17. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
18. Affective Neuropsychiatric Symptoms as Early Signs of Dementia Risk in Older Adults.
Jang JY; Ho JK; Blanken AE; Dutt S; Nation DA;
J Alzheimers Dis; 2020; 77(3):1195-1207. PubMed ID: 32925031
[TBL] [Abstract][Full Text] [Related]
19. Association Between Neuropsychiatric Symptom Trajectory and Conversion to Alzheimer Disease.
Lo TWB; Karameh WK; Barfett JJ; Fornazzari LR; Munoz DG; Schweizer TA; Fischer CE;
Alzheimer Dis Assoc Disord; 2020; 34(2):141-147. PubMed ID: 31633557
[TBL] [Abstract][Full Text] [Related]
20. Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.
Krell-Roesch J; Vassilaki M; Mielke MM; Kremers WK; Lowe VJ; Vemuri P; Machulda MM; Christianson TJ; Syrjanen JA; Stokin GB; Butler LM; Traber M; Jack CR; Knopman DS; Roberts RO; Petersen RC; Geda YE
Transl Psychiatry; 2019 Mar; 9(1):123. PubMed ID: 30923322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
